Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry

Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Beatriz Lara, Esther Rodriguez, Pietro Pirina, Ignacio Blanco, Marc Miravitlles

Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Session: New frontiers in the management of interstitial and orphan lung diseases
Session type: Oral Presentation
Number: 4492
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Beatriz Lara, Esther Rodriguez, Pietro Pirina, Ignacio Blanco, Marc Miravitlles. Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry. Eur Respir J 2015; 46: Suppl. 59, 4492

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015

The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Screening for alpha1-antitrypsin deficiency at a university hospital
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

Medical and demographic loss of population due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016


Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Investigation of sarcopenia in Japanese COPD patients
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015

Differences in disease severity between combination treatments in a Swedish population
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients
Source: Eur Respir J 2005; 26: 616-622
Year: 2005



Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013

Assessment of quality of life (SGRQ) in patients with alpha-1-antitrypsin deficiency– Analysis from the German registry
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016


Defining asthma COPD overlap syndrome (ACOS): A population based study
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Prevalence of chronic kidney disease (CKD) in the UK COPD population
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Productivity losses in COPD – A population-based survey.
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Eosinophilic phenotypes of overlapping respiratory diseases in an Italian general population sample
Source: International Congress 2014 – Epidemiology of asthma
Year: 2014